PAIN and ACYCLOVIR

PatientsVille

Find and Compare Side Effects

PAIN Symptoms and Causes

Pain is a signal in your nervous system that something may be wrong. It is an unpleasant feeling, such as a prick, tingle, sting, burn, or ache. Pain may be sharp or dull. It may come and go, or it may be constant. You may feel Pain in one area of your body, such as your back, abdomen, chest, pelvis, or you may feel Pain all over

Pain can be helpful in diagnosing a problem. If you never felt Pain, you might seriously hurt yourself without knowing it, or you might not realize you have a medical problem that needs treatment.

There are two types of Pain: acute and chronic. Acute Pain usually comes on suddenly, because of a disease, injury, or inflammation. It can often be diagnosed and treated. It usually goes away, though sometimes it can turn into chronic Pain. Chronic Pain lasts for a long time, and can cause severe problems.

Pain is not always curable, but there are many ways to treat it. Treatment depends on the cause and type of Pain. Pain relievers and other medicines, acupuncture, physical therapy, and sometimes surgery may be helpful.

PAIN Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

Prevalence of Pain; Response to analgesic treatment; The cause of Pain during hospitalization; Number of patients reporting Pain to heath care personnel; Proportion of physicians who know the patient is in Pain according to the evolution in medical chart; Number of nurses who know that the patient has Pain according to medical chart; Proportion of hospitalized patients treated for Pain; Type of analgesic treatment received; Number of patients with Pain evaluated by a Pain specialist

Dietary Supplement: Administration of L.reuteri in children with abdominal Pain; Dietary Supplement: Administration of placebo in children with abdominal Pain; Dietary Supplement: Administration of L.reuteri in children with constipation; Dietary Supplement: Administration of placebo in children with constipation

Outcome Measures:

Intensity of abdominal Pain; Severity of chronic constipation; Intensity of abdominal Pain after treatment; Severity of chronic constipation after treatment

Change from baseline in Pain-related disability, as measured by the Brief Pain Inventory - Pain Interference scale, at 3-month post-intervention.; Change from baseline in neuropathic Pain intensity, as measured by the Neuropathic Pain Symptom Inventory, at 3 months post-intervention; Change from baseline in Pain severity, as measured by the Brief Pain Inventory - Pain Severity scale, at 3 months post-intervention; Change from baseline in mood states, as measured by the Profile of Mood States scale, at 3 months post-intervention; Overall change in status from baseline, as measured by Patient Global Impression of Change scale, at 3 months post-intervention; Change from baseline in stress, as measured by the Perceived Stress Scale, at 3 months post-intervention; Change from baseline in depressive symptoms, as measured by the Patient Health Questionnaire - 9 scale, at 3 months post-intervention; Change from baseline in Pain catastrophizing, as measured by the Pain Catastrophizing Scale, at 3 months post-intervention.; Change from baseline in mindfulness, as measured by the Five Facet Mindfulness Questionnaire, at 3 months post-intervention.; Change from baseline in quality of life, as measured by the Short-Form-12 Health Survey, at 3 months post-intervention.; Change from pre-intervention in biomarkers of stress, as measured by hair cortisol levels, at 3 months post-intervention.; Change from baseline in immune function, as measured by blood levels of interleukin-4, interleukin-6, interleukin-10, tumor necrosis factor - alpha, and C reactive protein, at 3 months post-intervention.; Change from baseline in biomarkers of stress, as measured by telomere length, at 3 months post-intervention.; Change from pre-intervention in neuronal health, as measured by white matter integrity, at 2 weeks post-intervention.; Change from pre-intervention in brain areas associated with emotional regulation, as measured by blood flow in the brain seen in functional magnetic imaging, at 2 weeks post-intervention.; Change from pre-intervention in brain structure, as measured by changes in structural volume different areas of the brain, at 2 weeks post-intervention.

If you think you may have a medical emergency, call your doctor or 911 immediately.

By accessing this website, you are indicating your acknowledgement and acceptance of these Terms of Use. These Terms of Use are subject to change by WinFirst LLC at any time in its discretion. Your use of WinFirst LLC Site after such changes are implemented constitutes your acknowledgement and acceptance of the changes. Please consult these Terms of Use regularly.
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.